Arvinas
http://arvinas.com/Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins.
Total raised: $96.6M
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 04.04.2018 | Series C | $55M | - | Arvinas Co... |
| 21.10.2015 | Series B | $41.6M | - | Arvinas Cl... |
Mentions in press and media 8
| Date | Title | Description | Category | Author | Source |
| 09.04.2018 | The biotec... | Julie Papanek Grant, a partner... | - | - | medcitynew... |
| 05.04.2018 | Term Sheet... | GOT MONEY Good morning, Term ... | - | - | fortune.co... |
| 04.04.2018 | Arvinas Co... | Arvinas, LLC, a New Haven, Con... | USA | - | finsmes.co... |
| 04.04.2018 | Arvinas Co... | Arvinas LLC, a private biotech... | - | - | citybizlis... |
| 04.01.2018 | Pfizer and... | So what’s attracting the big... | - | - | medcitynew... |
| 21.10.2015 | Arvinas Cl... | Arvinas LLC, a New Haven, CT-b... | USA | - | finsmes.co... |
| 21.10.2015 | Arvinas ra... | Arvinas’ science comes from ... | - | - | medcitynew... |
| 16.10.2014 | Venture fi... | The company’s had a dozen ex... | - | - | medcitynew... |